Contact the editorial desk.

Glow Medicinal publishes editorial summaries of the peer-reviewed research literature on the GLOW peptide blend — GHK-Cu, BPC-157, and TB-500. We are not a clinic, a vendor, or a pharmacy. We cannot answer questions about personal health, dosing recommendations, or peptide sourcing.

For citation corrections: if you have identified an error in our citations — a wrong PMID, a misquoted finding, a broken DOI — please reach out. We take citation accuracy seriously and will correct errors promptly.

For editorial inquiries: questions about our coverage, scope, or editorial methodology are welcome.

What we cannot help with: sourcing questions, vendor recommendations, personal health questions, prescription inquiries, clinical consultations, or protocol advice. This site is an editorial digest of published science.

The GLOW peptide blend literature is constituent-level: GHK-Cu, BPC-157, and TB-500 have each been studied independently, but no controlled trial has examined the three in combination ^[23]. If you have found a published controlled trial we have not covered, we want to know. Correct, complete, and cited: that is the standard we hold ourselves to.